370 related articles for article (PubMed ID: 30033362)
1. Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19.
Hua JT; Ahmed M; Guo H; Zhang Y; Chen S; Soares F; Lu J; Zhou S; Wang M; Li H; Larson NB; McDonnell SK; Patel PS; Liang Y; Yao CQ; van der Kwast T; Lupien M; Feng FY; Zoubeidi A; Tsao MS; Thibodeau SN; Boutros PC; He HH
Cell; 2018 Jul; 174(3):564-575.e18. PubMed ID: 30033362
[TBL] [Abstract][Full Text] [Related]
2. Biology and Clinical Implications of the 19q13 Aggressive Prostate Cancer Susceptibility Locus.
Gao P; Xia JH; Sipeky C; Dong XM; Zhang Q; Yang Y; Zhang P; Cruz SP; Zhang K; Zhu J; Lee HM; Suleman S; Giannareas N; Liu S; ; Tammela TLJ; Auvinen A; Wang X; Huang Q; Wang L; Manninen A; Vaarala MH; Wang L; Schleutker J; Wei GH
Cell; 2018 Jul; 174(3):576-589.e18. PubMed ID: 30033361
[TBL] [Abstract][Full Text] [Related]
3. An NKX3.1 binding site polymorphism in the l-plastin promoter leads to differential gene expression in human prostate cancer.
Chen C; Cai Q; He W; Li Z; Zhou F; Liu Z; Zhong G; Chen X; Zhao Y; Dong W; Huang J; Zheng J; Lin T
Int J Cancer; 2016 Jan; 138(1):74-86. PubMed ID: 26148677
[TBL] [Abstract][Full Text] [Related]
4. Modulation of long noncoding RNAs by risk SNPs underlying genetic predispositions to prostate cancer.
Guo H; Ahmed M; Zhang F; Yao CQ; Li S; Liang Y; Hua J; Soares F; Sun Y; Langstein J; Li Y; Poon C; Bailey SD; Desai K; Fei T; Li Q; Sendorek DH; Fraser M; Prensner JR; Pugh TJ; Pomerantz M; Bristow RG; Lupien M; Feng FY; Boutros PC; Freedman ML; Walsh MJ; He HH
Nat Genet; 2016 Oct; 48(10):1142-50. PubMed ID: 27526323
[TBL] [Abstract][Full Text] [Related]
5. Identification of an inhibitory cis-element in the promoter region of human homeobox gene NKX3.1.
Anli J; Pengju Z; Xiaoyan H; Wenwei C; Zhifang L; Feng K; Huiqing Y; Jianye Z
Prostate; 2006 Sep; 66(12):1339-46. PubMed ID: 16845664
[TBL] [Abstract][Full Text] [Related]
6. Risk SNP-Mediated Enhancer-Promoter Interaction Drives Colorectal Cancer through Both
Tian J; Lou J; Cai Y; Rao M; Lu Z; Zhu Y; Zou D; Peng X; Wang H; Zhang M; Niu S; Li Y; Zhong R; Chang J; Miao X
Cancer Res; 2020 May; 80(9):1804-1818. PubMed ID: 32127356
[TBL] [Abstract][Full Text] [Related]
7. Long-range interaction and correlation between MYC enhancer and oncogenic long noncoding RNA CARLo-5.
Kim T; Cui R; Jeon YJ; Lee JH; Lee JH; Sim H; Park JK; Fadda P; Tili E; Nakanishi H; Huh MI; Kim SH; Cho JH; Sung BH; Peng Y; Lee TJ; Luo Z; Sun HL; Wei H; Alder H; Oh JS; Shim KS; Ko SB; Croce CM
Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4173-8. PubMed ID: 24594601
[TBL] [Abstract][Full Text] [Related]
8. lncRNA PCAT19 promotes the proliferation of laryngocarcinoma cells via modulation of the miR-182/PDK4 axis.
Xu S; Guo J; Zhang W
J Cell Biochem; 2019 Aug; 120(8):12810-12821. PubMed ID: 30868666
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of regulatory SNPs that modulate transcription factor chromatin binding and gene expression in prostate cancer.
Jin HJ; Jung S; DebRoy AR; Davuluri RV
Oncotarget; 2016 Aug; 7(34):54616-54626. PubMed ID: 27409348
[TBL] [Abstract][Full Text] [Related]
10. A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression.
Meyer KB; Maia AT; O'Reilly M; Ghoussaini M; Prathalingam R; Porter-Gill P; Ambs S; Prokunina-Olsson L; Carroll J; Ponder BA
PLoS Genet; 2011 Jul; 7(7):e1002165. PubMed ID: 21814516
[TBL] [Abstract][Full Text] [Related]
11. Integrative Genomic Analysis Predicts Causative
Zhang Y; Manjunath M; Zhang S; Chasman D; Roy S; Song JS
Cancer Res; 2018 Apr; 78(7):1579-1591. PubMed ID: 29351903
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic insights into genetic susceptibility to prostate cancer.
Tian P; Zhong M; Wei GH
Cancer Lett; 2021 Dec; 522():155-163. PubMed ID: 34560228
[TBL] [Abstract][Full Text] [Related]
13. The identification of an ESCC susceptibility SNP rs920778 that regulates the expression of lncRNA HOTAIR via a novel intronic enhancer.
Zhang X; Zhou L; Fu G; Sun F; Shi J; Wei J; Lu C; Zhou C; Yuan Q; Yang M
Carcinogenesis; 2014 Sep; 35(9):2062-7. PubMed ID: 24788237
[TBL] [Abstract][Full Text] [Related]
14. An Osteoporosis Risk SNP at 1p36.12 Acts as an Allele-Specific Enhancer to Modulate LINC00339 Expression via Long-Range Loop Formation.
Chen XF; Zhu DL; Yang M; Hu WX; Duan YY; Lu BJ; Rong Y; Dong SS; Hao RH; Chen JB; Chen YX; Yao S; Thynn HN; Guo Y; Yang TL
Am J Hum Genet; 2018 May; 102(5):776-793. PubMed ID: 29706346
[TBL] [Abstract][Full Text] [Related]
15. Integrative functional genomics identifies an enhancer looping to the SOX9 gene disrupted by the 17q24.3 prostate cancer risk locus.
Zhang X; Cowper-Sal lari R; Bailey SD; Moore JH; Lupien M
Genome Res; 2012 Aug; 22(8):1437-46. PubMed ID: 22665440
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of miR-146a by YY1 depletion correlates with delayed progression of prostate cancer.
Huang Y; Tao T; Liu C; Guan H; Zhang G; Ling Z; Zhang L; Lu K; Chen S; Xu B; Chen M
Int J Oncol; 2017 Feb; 50(2):421-431. PubMed ID: 28101571
[TBL] [Abstract][Full Text] [Related]
17. An enhancer from the 8q24 prostate cancer risk region is sufficient to direct reporter gene expression to a subset of prostate stem-like epithelial cells in transgenic mice.
Ting MC; Liao CP; Yan C; Jia L; Groshen S; Frenkel B; Roy-Burman P; Coetzee GA; Maxson R
Dis Model Mech; 2012 May; 5(3):366-74. PubMed ID: 22279083
[TBL] [Abstract][Full Text] [Related]
18. Characterization of human collagen XVIII promoter 2: interaction of Sp1, Sp3 and YY1 with the regulatory region and a SNP that increases transcription in hepatocytes.
Armelin-Correa LM; Lin CJ; Barbosa A; Bagatini K; Winnischofer SM; Sogayar MC; Passos-Bueno MR
Matrix Biol; 2005 Dec; 24(8):550-9. PubMed ID: 16229994
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive functional annotation of 77 prostate cancer risk loci.
Hazelett DJ; Rhie SK; Gaddis M; Yan C; Lakeland DL; Coetzee SG; ; ; Henderson BE; Noushmehr H; Cozen W; Kote-Jarai Z; Eeles RA; Easton DF; Haiman CA; Lu W; Farnham PJ; Coetzee GA
PLoS Genet; 2014 Jan; 10(1):e1004102. PubMed ID: 24497837
[TBL] [Abstract][Full Text] [Related]
20. Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model.
Gabril MY; Onita T; Ji PG; Sakai H; Chan FL; Koropatnick J; Chin JL; Moussa M; Xuan JW
Gene Ther; 2002 Dec; 9(23):1589-99. PubMed ID: 12424611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
